Quant Healthcare Fund
Direct · Growth ₹18.19
21 Jul 2026
NAV
21.7%
3Y CAGR
20.2%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
0.39
Sharpe
-25.2%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.31 L | 15.6% | -27.4% | 81.9% |
| 3 Years | ₹36.00 L | ₹43.99 L | 14.0% | 11.7% | 16.1% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 15.6% | 14.5% | 13.7% | +1.2% |
| 3 Years | 14.0% | 11.2% | 17.2% | +2.8% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 15.7% | 8.1% | -12.3% | 67.6% | 0.39 | 1.39 | 73% | — | — |
| 3 Years | 21.7% | 21.7% | 21.7% | 21.7% | — | — | 100% | — | — |
-25.2%
Max Drawdown
6 mo
Drawdown Duration
16 mo
Recovery Time
-7.6%
Avg Drawdown
Calmar Ratio by Duration
0.62
1Y
0.86
3Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +13.41 | 0.83 | 96.8% | 78.0% | 11.7% | -3.4% |
| 3 Years | +15.07 | 0.82 | 95.0% | 74.8% | 21.7% | 6.7% |
| 5 Years | +8.09 | 0.82 | 94.8% | 74.8% | 12.6% | 4.1% |
| 7 Years | +5.31 | 0.82 | 94.8% | 74.8% | 8.9% | 2.9% |
| 10 Years | +3.29 | 0.82 | 94.8% | 74.8% | 6.1% | 2.0% |
| 12 Years | +2.52 | 0.82 | 94.8% | 74.8% | 5.1% | 1.7% |
| 15 Years | +1.77 | 0.82 | 94.8% | 74.8% | 4.0% | 1.4% |
10
Total Holdings
63.7%
Top 10 Weight
4
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | HFCL Limited | 10.76% |
| 2 | Zydus Wellness Ltd | 9.44% |
| 3 | Aster DM Healthcare Limited | 8.96% |
| 4 | Concord Biotech Limited | 8.84% |
| 5 | SMS Pharmaceuticals Limited | 8.15% |
| 6 | Pfizer Ltd | 5.44% |
| 7 | Aurobindo Pharma Limited | 5.21% |
| 8 | Strides Pharma Science Ltd | 2.86% |
| 9 | Glaxosmithkline Pharmaceuticals Ltd | 2.04% |
| 10 | Max Healthcare Institute Limited | 2.03% |